Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07892092) titled 'Long-Term Cardiovascular Impact of ArmoLIPID Cholesterol Plus: An In Silico Study Using Digital Twins' on Oct. 17.
Study Type: Observational
Primary Sponsor: Aeterna Medical Solutions SL
Condition:
Hypercholesterolemia
Cardiovascular Risk
Recruitment Status: Not recruiting
Date of First Enrollment: September 1, 2026
Target Sample Size: 100000
Countries of Recruitment:
Spain
To know more, visit https://clinicaltrials.gov/study/NCT07892092
Disclaimer: Curated by HT Syndication....